SMTL ID : 5dfd.1

Crystal structure of BRD2(BD2) W370F mutant with ligand 28 bound

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.50 Å

Oligo State

monomer

Ligands

1 x 59E: methyl [(4S)-6-(1H-indol-4-yl)-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]acetate(Non-covalent)

59E.1: 9 residues within 4Å: Chain A: P.30, F.31, V.35, L.42, C.84, N.88, H.92, V.94, M.97 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:P.30, A:F.31, A:V.35, A:L.42, A:V.94, A:V.94 Hydrogen bonds: A:N.88 Salt bridges: A:H.92 pi-Stacking: A:H.92

1 x GOL: GLYCEROL(Non-functional Binders)

GOL.2: 3 residues within 4Å: Chain A: Y.27, M.97, K.100 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:K.100, A:K.100

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Baud, M.G. et al., New Synthetic Routes to Triazolo-benzodiazepine Analogues: Expanding the Scope of the Bump-and-Hole Approach for Selective Bromo and Extra-Terminal (BET) Bromodomain Inhibition. J.Med.Chem. (2016)

Release Date

2015-11-11

Peptides

Bromodomain-containing protein 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Bromodomain-containing protein 2

Related Entries With Identical Sequence